JENNY CUMMINGS: Open Payments
NPI 1194174086 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,942 in 111 payments from 22 companies in 2025. Trend: 2023 $1,356 · 2024 $1,712 · 2025 $1,942
Food & beverage: $1,942
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $353 |
| ABBVIE INC. | 20 | $334 |
| AstraZeneca Pharmaceuticals LP | 12 | $217 |
| Merck Sharp & Dohme LLC | 10 | $147 |
| Daiichi Sankyo Inc. | 4 | $100 |
| Janssen Biotech, Inc. | 4 | $86 |
| Exelixis Inc. | 5 | $81 |
| Eisai Inc. | 4 | $79 |
| GlaxoSmithKline, LLC. | 5 | $78 |
| PFIZER INC. | 4 | $68 |
Products named: KISQALI, EPKINLY, Enhertu, KEYTRUDA, IMFINZI, VENCLEXTA, CABOMETYX, Lenvima.
Industry payments across AR — which companies pay providers there.
